This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Nov;49(11):2217-9.

doi: 10.1093/rheumatology/keq249a. Epub 2010 Sep 12.

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

Tina Ding¹, Jo Ledingham, Raashid Luqmani, Sarah Westlake, Kimme Hyrich, Mark Lunt, Patrick Kiely, Marwan Bukhari, Rikki Abernethy, Ailsa Bosworth, Andrew Ostor, Kate Gadsby, Frank McKenna, Diana Finney, Josh Dixey, Chris Deighton; Standards, Audit and Guidelines Working Group of BSR Clinical Affairs Committee; BHPR

Affiliations

PMID: 20837498
DOI: 10.1093/rheumatology/keq249a

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

Tina Ding et al. Rheumatology (Oxford). 2010 Nov.

. 2010 Nov;49(11):2217-9.

doi: 10.1093/rheumatology/keq249a. Epub 2010 Sep 12.

Authors

Tina Ding¹, Jo Ledingham, Raashid Luqmani, Sarah Westlake, Kimme Hyrich, Mark Lunt, Patrick Kiely, Marwan Bukhari, Rikki Abernethy, Ailsa Bosworth, Andrew Ostor, Kate Gadsby, Frank McKenna, Diana Finney, Josh Dixey, Chris Deighton; Standards, Audit and Guidelines Working Group of BSR Clinical Affairs Committee; BHPR

Affiliation

¹ Rheumatology Department, Royal Derby Hospital, Derby, UK. tina.ding@doctors.net.uk

PMID: 20837498
DOI: 10.1093/rheumatology/keq249a

No abstract available

PubMed Disclaimer

Similar articles

Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
Bhalla AK, Samaranayaka M. Bhalla AK, et al. Rheumatology (Oxford). 2008 Oct;47(10):1591; author reply 1591. doi: 10.1093/rheumatology/ken322. Epub 2008 Aug 1. Rheumatology (Oxford). 2008. PMID: 18676499 No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
Deighton C, Hyrich K, Ding T, Ledingham J, Lunt M, Luqmani R, Kiely P, Bukhari M, Abernethy R, Ostor A, Bosworth A, Gadsby K, McKenna F, Finney D, Dixey J; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. Deighton C, et al. Rheumatology (Oxford). 2010 Jun;49(6):1197-9. doi: 10.1093/rheumatology/keq006a. Epub 2010 Mar 22. Rheumatology (Oxford). 2010. PMID: 20308121 No abstract available.
Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
Deighton CM, George E, Kiely PD, Ledingham J, Luqmani RA, Scott DG. Deighton CM, et al. Rheumatology (Oxford). 2006 Jun;45(6):649-52. doi: 10.1093/rheumatology/kel053. Epub 2006 Mar 9. Rheumatology (Oxford). 2006. PMID: 16527881 No abstract available.
TNF inhibitors - new and old agents for rheumatoid arthritis.
Simsek I. Simsek I. Bull NYU Hosp Jt Dis. 2010;68(3):204-10. Bull NYU Hosp Jt Dis. 2010. PMID: 20969553 Review.
Predictors of response to TNF inhibitors in rheumatoid arthritis - do we have new tools for personalized medicine?
Simsek I. Simsek I. Bull NYU Hosp Jt Dis. 2012;70(3):187-90. Bull NYU Hosp Jt Dis. 2012. PMID: 23259626 Review.

See all similar articles

Cited by

Drug advances in inflammatory bowel disease.
Speight RA, Mansfield JC. Speight RA, et al. Clin Med (Lond). 2013 Aug;13(4):378-82. doi: 10.7861/clinmedicine.13-4-378. Clin Med (Lond). 2013. PMID: 23908509 Free PMC article. Review.
Management of perioperative tumour necrosis factor α inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis.
Goodman SM, Menon I, Christos PJ, Smethurst R, Bykerk VP. Goodman SM, et al. Rheumatology (Oxford). 2016 Mar;55(3):573-82. doi: 10.1093/rheumatology/kev364. Epub 2015 Oct 7. Rheumatology (Oxford). 2016. PMID: 26447162 Free PMC article.
Failure of anti-TNF therapy to reactivate previously septic prosthetic joints.
Manolios N, Burneikis A, Spencer D, Howe G. Manolios N, et al. BMJ Case Rep. 2013 Jul 8;2013:bcr2013009827. doi: 10.1136/bcr-2013-009827. BMJ Case Rep. 2013. PMID: 23839609 Free PMC article.
Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting.
Simonetti O, Rizzetto G, Molinelli E, Diotallevi F, Radi G, Cirioni O, D'Errico MM, Offidani A. Simonetti O, et al. Healthcare (Basel). 2021 Apr 1;9(4):401. doi: 10.3390/healthcare9040401. Healthcare (Basel). 2021. PMID: 33916122 Free PMC article. Review.
Prosthetic joint infection.
Tande AJ, Patel R. Tande AJ, et al. Clin Microbiol Rev. 2014 Apr;27(2):302-45. doi: 10.1128/CMR.00111-13. Clin Microbiol Rev. 2014. PMID: 24696437 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information